Description: This presentation will present a series of difficult clinical cases that identify many of the complex problems we see on a day-to-day basis in the management of immune mediated thrombocytopenia.
Speaker: Mark Crowther, MD MSc FRCPC FRSC
Chair, Department of Medicine
Leo Pharma Chair in Thromboembolism Research
At the end of this session, participants will be able to:
1. Identify common issues in the management of ITP
2. Distinguish between those patients who do, and do not, require therapy
3. Appraise evidence for novel therapies in this area
Accreditation: This activity is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada and approved by the Canadian Association of Pathologists (CAP-AC). You may claim a maximum of 1.0 hours. #
This webinar was co-developed with SOBI and the CHS and was planned to achieve scientific integrity, objectivity and balance.
Target Audience: Hematologists and Residents
Medical Expert (the integrating role)
Conflict of Interest: Advisory board and speaker’s bureaus: Astra-Zeneca, Bayer, Pfizer, CSL Behring, Hemostasis Reference
Laboratories, Syneos Health, Eversana. Description of relationship(s) : Preparation of educational materials, presentation, membership on advisory boards